Voxvoganan | m-entrepreneurship.com

Product Name :
Voxvoganan

Search keywords :
Voxvoganan

drugId :
null

Target Vo:
Undisclosed

Target Vo Short Name :
Undisclosed

Moa_Name:
Cell membrane modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Lytix Biopharma As

Active Company_Name :
Pharma Holdings AS

Active Indication_Name:
Coronavirus Disease 2019 (COVID-19)

In Active Indication_Name:
Gram-Positive Bacterial Infections

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Alemtuzumab web
Figitumumab Purity & Documentation
DLST Antibody: DLST Antibody is an unconjugated, approximately 41 kDa, rabbit-derived, anti-DLST polyclonal antibody. DLST Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF, expriments in mouse and predicted: human, rat, dog, pig, cow, horse, rabbit, sheep background without labeling.

Author: Betaine hydrochloride

Related Posts